Being in business for the past 25 Years, having acquired excellent knowledge about the market, technology, the products and the customers, his proficiency on a variety of subjects and expertise plays an instrumental role in the organization. Mr Neeraj is actively involved in all the important strategies and decision makings of the company and also holds a position in Board of Directors in Imperial Life Sciences Pvt. Ltd.
He has traveled extensively all-round the globe and has played a significant role for the company as a business partner in India for brands like Thermo Fisher, Nanostring, Perkin Elmer, Oxford Nanopore , Illumina, Pacific Bio, Merck, Agena, etc. Leading the life science company Imperial Life Science (ILS) since 1999 driven to new heights of leadership and expansions in India with more than 300 employees in fields of Genomics, Cell Biology, Research & Development and Advanced Molecular Diagnostics.
Mr. Gupta is a member of Confederation of Indian Industry (CII) and an active speaker in FICCI and CII healthcare and technology conferences and meetings. He has been invited by many media houses to speak on the topics like future of Healthcare investment, personalized medicines, Genomics technology etc. He was also recognized by FORBES Magazine in May 2021 as “Insightful Icon”.
With a vision to transform "Genetics for the Billions", Genes2Me is the brainchild of Neeraj Gupta. He is the man behind inception of Genes2Me Pvt. Ltd. which is now a leading IVD solutions manufacturer with revolutionary and innovative Genetic based product offerings comprising of NGS clinical assays, molecular POC rapid PCR testing solution, RT-PCR Kits, Rapid Antigen/ Antibody Testing Kits and Molecular Biology reagents. Under his leadership, company has been able to contribute significantly in the fight against COVID-19 where the company has contributed 1 in every 5 RTPCR tests conducted in India till now and produced more than 70 million test kits.
His mission is to bridge the gap between resource limited areas with advanced healthcare technologies in India and gradually across the globe. His natural flair for thinking big, robust and never exhausting energy, belief and will power to achieve are chiefly responsible for the sprouting of this unique concept. Added to it, are his close association with cream layer of the Industry thought leaders & key opinion leaders, wide exposure all around global market and propensity to envisage the right business opportunity – have set the ball rolling.
Soon after conceiving the idea, he has traveled throughout the length and breadth of world, interacting and holding long sessions not only with heads of various Hospital, Health care Institutions, distributors & Medical University, but also with the Doctors, researchers, faculty & students fraternity and spent considerable time, resource and energy on the financial prospects and has given the Project its ultimate shape and structure. Under his leadership, Genes2Me modernized its state-of-art manufacturing facility of IVD kits and branched out to many parts of the world, with 80+ distributors globally across 40+ countries.
Alongside, the company is also one of the renowned genetic testing service providers with wide menu of test range targeting infectious and non-infectious diseases, oncology rare diseases and prenatal/postnatal genetic diseases.
Since its inception in 2016, Genes2me has been constantly striving towards setting a benchmark in the diagnostics space by introducing premium quality (Made in India) diagnostic kits which are CE-IVD, ISO-13485:2016, and ISO 9001:2015 certified, assuring our clients of unparalleled quality and compliance with international standards.
© 2025 Genes2me. All rights reserved.